Dongfang Liu, the CHIEF MEDICAL OFFICER of $NUVB, sold 10,000 shares of the company on 11-26-2025 for an estimated $80,000. We received data on the trade from a recent SEC filing. This was a sale of approximately 35.7% of their shares of this class of stock. Following this trade, they now own 18,000 shares of this class of $NUVB stock.
$NUVB Insider Trading Activity
$NUVB insiders have traded $NUVB stock on the open market 16 times in the past 6 months. Of those trades, 7 have been purchases and 9 have been sales.
Here’s a breakdown of recent trading of $NUVB stock by insiders over the last 6 months:
- GARY HATTERSLEY (CHIEF SCIENTIFIC OFFICER) has made 0 purchases and 3 sales selling 469,051 shares for an estimated $3,169,591.
- DAVID C. HANLEY (CHIEF TECHNICAL OPERATIONS) sold 200,000 shares for an estimated $1,427,680
- DAVID HUNG (PRESIDENT AND CEO) purchased 500,000 shares for an estimated $893,500
- DONGFANG LIU (CHIEF MEDICAL OFFICER) has made 0 purchases and 5 sales selling 70,000 shares for an estimated $443,101.
- COLLEEN SJOGREN (Chief Commercial Officer) purchased 50,000 shares for an estimated $90,350
- KERRY WENTWORTH (CHIEF REGULATORY OFFICER) has made 2 purchases buying 50,000 shares for an estimated $89,740 and 0 sales.
- STACY MARKEL (CHIEF PEOPLE OFFICER) purchased 10,000 shares for an estimated $17,100
- PHILIPPE SAUVAGE (Chief Financial Officer) has made 2 purchases buying 7,300 shares for an estimated $13,215 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$NUVB Hedge Fund Activity
We have seen 120 institutional investors add shares of $NUVB stock to their portfolio, and 80 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- OCTAGON CAPITAL ADVISORS LP removed 5,058,000 shares (-65.8%) from their portfolio in Q3 2025, for an estimated $18,714,600
- MPM BIOIMPACT LLC removed 4,622,590 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $17,103,583
- CITADEL ADVISORS LLC removed 3,228,523 shares (-58.4%) from their portfolio in Q3 2025, for an estimated $11,945,535
- NUVEEN, LLC added 3,081,367 shares (+207.5%) to their portfolio in Q3 2025, for an estimated $11,401,057
- ROSALIND ADVISORS, INC. removed 2,451,500 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $4,780,425
- JANE STREET GROUP, LLC added 2,322,233 shares (+inf%) to their portfolio in Q3 2025, for an estimated $8,592,262
- OMEGA FUND MANAGEMENT, LLC removed 2,211,639 shares (-20.0%) from their portfolio in Q3 2025, for an estimated $8,183,064
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$NUVB Analyst Ratings
Wall Street analysts have issued reports on $NUVB in the last several months. We have seen 8 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Truist Securities issued a "Buy" rating on 11/24/2025
- Citizens issued a "Market Outperform" rating on 11/20/2025
- B. Riley Securities issued a "Buy" rating on 11/19/2025
- RBC Capital issued a "Outperform" rating on 11/04/2025
- Wedbush issued a "Outperform" rating on 10/13/2025
- Jefferies issued a "Buy" rating on 09/30/2025
- HC Wainwright & Co. issued a "Buy" rating on 09/19/2025
To track analyst ratings and price targets for $NUVB, check out Quiver Quantitative's $NUVB forecast page.
$NUVB Price Targets
Multiple analysts have issued price targets for $NUVB recently. We have seen 8 analysts offer price targets for $NUVB in the last 6 months, with a median target of $10.0.
Here are some recent targets:
- Gregory Renza from Truist Securities set a target price of $11.0 on 11/24/2025
- Silvan Tuerkcan from Citizens set a target price of $10.0 on 11/20/2025
- Mayank Mamtani from B. Riley Securities set a target price of $12.0 on 11/19/2025
- Leonid Timashev from RBC Capital set a target price of $8.0 on 11/04/2025
- David Nierengarten from Wedbush set a target price of $6.0 on 10/13/2025
- Farzin Haque from Jefferies set a target price of $10.0 on 09/30/2025
- Robert Burns from HC Wainwright & Co. set a target price of $10.0 on 09/19/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
